ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,154Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 345

$801K Total Retail Price of All Prescriptions

Rank: 3 out of 345

989 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 989 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

1% of this provider’s 14,739 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
METOPROLOL SUCCINATE 1,071 933 1 3
LISINOPRIL 929 798 2 1
FUROSEMIDE 745 611 3 6
METOPROLOL TARTRATE 741 692 4 4
ATORVASTATIN CALCIUM 715 656 5 9
AMLODIPINE BESYLATE 711 644 6 5
SIMVASTATIN 695 602 7 7
WARFARIN SODIUM 536 474 8 8
CARVEDILOL 478 345 9 2
ATENOLOL 473 457 10 13
OMEPRAZOLE 444 399 11 26
ISOSORBIDE MONONITRATE ER 426 346 12 10
LOSARTAN POTASSIUM 418 372 13 12
SPIRONOLACTONE 401 296 14 19
DIGOXIN 373 279 15 18
CLOPIDOGREL 335 281 16 11
PLAVIX 262 232 17 16
PRAVASTATIN SODIUM 259 230 18 14
NITROSTAT 251 203 19 24
POTASSIUM CHLORIDE 243 200 20 23
TRAMADOL HCL 204 148 21 60
HYDROCHLOROTHIAZIDE 184 183 22 17
LEVOTHYROXINE SODIUM 173 165 23 27
PANTOPRAZOLE SODIUM 165 153 24 54
KLOR-CON M20 164 133 25 30
METFORMIN HCL 159 155 26 38
AMLODIPINE BESYLATE-BENAZEPRIL 149 141 27 67
AMIODARONE HCL 148 98 28 21
HYDROCODONE-ACETAMINOPHEN 133 89 S3 29 39
DIOVAN 127 100 30 25
TAMSULOSIN HCL 114 101 31 72
RAMIPRIL 114 105 31 31
ALLOPURINOL 111 86 33 59
LIPITOR 110 89 34 43
GUANFACINE HCL 109 88 R 35 96
BENAZEPRIL HCL 108 92 36 62
BYSTOLIC 102 92 37 22
CRESTOR 99 97 38 15
PRADAXA 94 94 39 20
KLOR-CON 10 93 93 40 114
SERTRALINE HCL 88 76 41 75
SOTALOL 80 71 42 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 76 43 42
RANITIDINE HCL 75 63 44 49
CITALOPRAM HBR 73 72 45 95
PREDNISONE 70 63 46 124
MULTAQ 69 69 47 53
CLONIDINE HCL 64 48 48 40
HYDRALAZINE HCL 63 38 49 34
LOSARTAN-HYDROCHLOROTHIAZIDE 62 58 50 35
GLIPIZIDE XL 62 34 50 148
NADOLOL 60 58 52 149
ZOLPIDEM TARTRATE 58 58 53 56
COMBIVENT 57 47 54 154
GLIMEPIRIDE 55 35 55 64
DILTIAZEM ER 55 47 55 63
DIOVAN HCT 55 44 55 51
ZETIA 54 51 58 28
GABAPENTIN 51 38 59 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 27, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.